Human medicines European public assessment report (EPAR): Xeplion, paliperidone, Date of authorisation: 04/03/2011, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Namuscla, Mexiletine, Date of authorisation: 18/12/2018, Revision: 9, Status: Authorised

Development of a reflection paper on the use of external controls for evidence generation in regulatory decision-making - Scientific guideline

Biltricide

Insuman Basal and Comb 25

Integrilin

Mimpara

Concept paper on the development of a reflection paper on the use of External controls for evidence generation in regulatory decision-making

Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 6, Status: Authorised